EyePoint, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
EyePoint, Inc. (EYPT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$15.13 million for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-10
- EyePoint, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$15.07M, a 551.90% decline year-over-year.
- EyePoint, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$64.00K, a 101.17% decline year-over-year.
- EyePoint, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $2.37M.
- EyePoint, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $13.58M.
- EyePoint, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$4.46M.
- EyePoint, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$6.73M, a 10301.52% decline from fiscal 2014.
- EyePoint, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $66.00K, a 98.96% decline from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$15.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | -$15.07M derived: sum of 2 quarters · filed 2018-05-10 | -$15.13M 10-Q · filed 2018-05-10 | -$12.76M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | -$64.00K 10-Q · filed 2018-02-08 | $2.31M derived: sum of 3 quarters · filed 2018-02-08 | $5.64M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-09-30 | -$64.00K 10-Q · filed 2017-11-08 | $2.31M derived: sum of 2 quarters · filed 2017-11-08 | $5.64M derived: sum of 3 quarters · filed 2018-05-10 | $8.03M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-13 | $5.71M derived: sum of 2 quarters · filed 2018-05-10 | $8.10M derived: sum of 3 quarters · filed 2018-05-10 | $13.58M 10-K · filed 2017-09-13 |
| 2017-03-31 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | $5.72M derived: sum of 2 quarters · filed 2018-05-10 | $11.20M 10-Q · filed 2018-05-10 | $5.88M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $7.87M 10-Q · filed 2018-02-08 | $2.55M derived: sum of 3 quarters · filed 2018-02-08 | $3.98M derived: sum of 4 quarters · filed 2018-02-08 |
| 2016-09-30 | $5.48M 10-Q · filed 2017-11-08 | $159.00K derived: sum of 2 quarters · filed 2017-11-08 | $1.59M derived: sum of 3 quarters · filed 2017-11-08 | $1.56M derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | -$5.32M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-13 | -$3.89M derived: sum of 2 quarters · filed 2017-09-13 | -$3.92M derived: sum of 3 quarters · filed 2017-09-13 | -$4.46M 10-K · filed 2017-09-13 |
| 2016-03-31 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | $1.41M derived: sum of 2 quarters · filed 2017-05-08 | $859.00K 10-Q · filed 2017-05-08 | -$26.00K derived: sum of 4 quarters · filed 2017-09-13 |
| 2015-12-31 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$574.00K 10-Q · filed 2017-02-09 | -$1.46M derived: sum of 3 quarters · filed 2017-09-13 | -$4.24M derived: sum of 4 quarters · filed 2017-09-13 |
| 2015-09-30 | -$546.00K 10-Q · filed 2016-11-08 | -$1.43M derived: sum of 2 quarters · filed 2017-09-13 | -$4.21M derived: sum of 3 quarters · filed 2017-09-13 | -$7.27M derived: sum of 4 quarters · filed 2017-09-13 |
| 2015-06-30 | -$885.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-13 | -$3.67M derived: sum of 2 quarters · filed 2017-09-13 | -$6.73M derived: sum of 3 quarters · filed 2017-09-13 | -$6.73M 10-K · filed 2017-09-13 |
| 2015-03-31 | -$2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-06 | -$5.84M derived: sum of 2 quarters · filed 2016-05-06 | -$5.85M 10-Q · filed 2016-05-06 | -$6.27M derived: sum of 4 quarters · filed 2016-09-13 |
| 2014-12-31 | -$3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | -$3.06M 10-Q · filed 2016-02-09 | -$3.49M derived: sum of 3 quarters · filed 2016-09-13 | -$5.75M derived: sum of 4 quarters · filed 2016-09-13 |
| 2014-09-30 | -$7.00K 10-Q · filed 2015-11-06 | -$428.00K derived: sum of 2 quarters · filed 2016-09-13 | -$2.69M derived: sum of 3 quarters · filed 2016-09-13 | -$1.38M derived: sum of 4 quarters · filed 2016-09-13 |
| 2014-06-30 | -$421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | -$2.69M derived: sum of 2 quarters · filed 2016-09-13 | -$1.38M derived: sum of 3 quarters · filed 2016-09-13 | $66.00K 10-K · filed 2016-09-13 |
| 2014-03-31 | -$2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-08 | -$955.00K derived: sum of 2 quarters · filed 2015-05-08 | $487.00K 10-Q · filed 2015-05-08 | $2.77M derived: sum of 4 quarters · filed 2015-09-10 |
| 2013-12-31 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | $2.75M 10-Q · filed 2015-02-06 | $5.03M derived: sum of 3 quarters · filed 2015-09-10 | |
| 2013-09-30 | $1.44M 10-Q · filed 2014-11-07 | $3.72M derived: sum of 2 quarters · filed 2015-09-10 | ||
| 2013-06-30 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-10 | $6.36M 10-K · filed 2015-09-10 | ||
| 2013-03-31 | $4.08M 10-Q · filed 2014-05-14 | |||
| 2012-06-30 | $606.00K 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |